Cargando…
Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Academy of Allergy, Asthma & Immunology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833501/ https://www.ncbi.nlm.nih.gov/pubmed/32710973 http://dx.doi.org/10.1016/j.jaci.2020.07.008 |
| _version_ | 1783642079993266176 |
|---|---|
| author | Manjaly Thomas, Zita-Rose Leuppi-Taegtmeyer, Anne Jamiolkowski, Dagmar Steveling-Klein, Esther Bellutti-Enders, Felicitas Scherer Hofmeier, Kathrin Hartmann, Karin |
| author_facet | Manjaly Thomas, Zita-Rose Leuppi-Taegtmeyer, Anne Jamiolkowski, Dagmar Steveling-Klein, Esther Bellutti-Enders, Felicitas Scherer Hofmeier, Kathrin Hartmann, Karin |
| author_sort | Manjaly Thomas, Zita-Rose |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7833501 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | American Academy of Allergy, Asthma & Immunology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78335012021-01-26 Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities Manjaly Thomas, Zita-Rose Leuppi-Taegtmeyer, Anne Jamiolkowski, Dagmar Steveling-Klein, Esther Bellutti-Enders, Felicitas Scherer Hofmeier, Kathrin Hartmann, Karin J Allergy Clin Immunol Covid-19 American Academy of Allergy, Asthma & Immunology 2020-10 2020-07-22 /pmc/articles/PMC7833501/ /pubmed/32710973 http://dx.doi.org/10.1016/j.jaci.2020.07.008 Text en © 2020 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Covid-19 Manjaly Thomas, Zita-Rose Leuppi-Taegtmeyer, Anne Jamiolkowski, Dagmar Steveling-Klein, Esther Bellutti-Enders, Felicitas Scherer Hofmeier, Kathrin Hartmann, Karin Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities |
| title | Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities |
| title_full | Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities |
| title_fullStr | Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities |
| title_full_unstemmed | Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities |
| title_short | Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities |
| title_sort | emerging treatments in covid-19: adverse drug reactions including drug hypersensitivities |
| topic | Covid-19 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833501/ https://www.ncbi.nlm.nih.gov/pubmed/32710973 http://dx.doi.org/10.1016/j.jaci.2020.07.008 |
| work_keys_str_mv | AT manjalythomaszitarose emergingtreatmentsincovid19adversedrugreactionsincludingdrughypersensitivities AT leuppitaegtmeyeranne emergingtreatmentsincovid19adversedrugreactionsincludingdrughypersensitivities AT jamiolkowskidagmar emergingtreatmentsincovid19adversedrugreactionsincludingdrughypersensitivities AT stevelingkleinesther emergingtreatmentsincovid19adversedrugreactionsincludingdrughypersensitivities AT belluttiendersfelicitas emergingtreatmentsincovid19adversedrugreactionsincludingdrughypersensitivities AT schererhofmeierkathrin emergingtreatmentsincovid19adversedrugreactionsincludingdrughypersensitivities AT hartmannkarin emergingtreatmentsincovid19adversedrugreactionsincludingdrughypersensitivities |